Abstract | OBJECTIVES: To evaluate whether the adjunct of an ultrasound contrast medium improves the detection rate of prostate cancer. METHOD: In 34 patients, scheduled to undergo a trans-perineal extended prostate biopsy, we carried out a color-Doppler ultrasound (CDU) of the prostate before and after i.v. injection of Levovist, an ultrasound contrast medium. Further bioptic samples were taken in the areas where a marked increase in vascularization was noticed. RESULTS: The overall diagnostic sensitivity, specificity and efficiency were respectively 72.7, 56.2 and 62.9% for transrectal ultrasound (TRUS); 80, 56.2 and 65.3% for CDU and 88.8, 54.5 and 68% for CDU after Levovist injection; 66.5, 72.6 and 65.1% for digito-rectal examination (DRE); 100, 51.4 and 65.4% for total PSA; and 100, 88.8 and 94.3% for PSA free/total. In the 16 patients with prostate carcinoma, the sensitivity of CDU after Levovist was 92.3, 66% for both DRE and TRUS, and 80% for DRE plus TRUS. CONCLUSIONS: Considering the cost and the results obtained (high sensitivity and low specificity), a routine use of Levovist does not seem indicated in patients undergoing prostatic biopsy. An exception may be represented by patients with both negative DRE and TRUS.
|
Authors | P Pepe, D Patanè, P Panella, F Aragona |
Journal | Prostate cancer and prostatic diseases
(Prostate Cancer Prostatic Dis)
Vol. 6
Issue 2
Pg. 159-62
( 2003)
ISSN: 1365-7852 [Print] England |
PMID | 12806376
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contrast Media
- Polysaccharides
- SHU 508
- Prostate-Specific Antigen
|
Topics |
- Aged
- Biopsy
- Contrast Media
- Health Care Costs
- Humans
- Male
- Middle Aged
- Polysaccharides
- Predictive Value of Tests
- Prostate-Specific Antigen
(blood)
- Prostatic Neoplasms
(diagnostic imaging)
- Rectum
(diagnostic imaging)
- Sensitivity and Specificity
- Ultrasonography, Doppler, Color
(economics, methods)
|